Bill Seeks to Block Funding to Biotechnology Firms of ‘Foreign Adversaries’

‘It is unacceptable for U.S. taxpayer dollars to be used to subsidize biotech companies of our foreign adversaries,’ says Rep. Raja Krishnamoorthi (D-Ill.).

The CCP's leading gene technology company, BGI Group, has been sued for patent infringement in several countries by Illumina, a multinational giant in gene sequencing. BGI operations have also been suspended in the United States and Hong Kong and it was found guilty of patent infringement in the UK. Pictured here is a BGI staffer testing for the CCP virus (COVID-19). STR/AFP

New legislation introduced to the House and Senate seeks to bar the United States from funding Chinese biotechnology companies that could pose a risk to national security.

The BIOSECURE Act would restrict federally funded medical providers from using products and services from biotechnology companies of concern, as well as from engaging in contracts with them or providing taxpayer-funded grants to them.